Predictors and long-term outcome of seizures in human immuno-deficiency virus (HIV)-negative cryptococcal meningitis

BMC Neurol. 2014 Oct 13:14:208. doi: 10.1186/s12883-014-0208-x.

Abstract

Background: Seizures are one of the most important neurologic complications of human immuno-deficiency virus (HIV)-negative cryptococcal meningitis. A better understanding of the risk associated factors can help predict those who will require treatment.

Methods: This 22-year retrospective study enrolled 180 patients. Prognostic variables independently associated with seizures or fatality were analyzed using stepwise logistic regression.

Results: Twenty-eight patients with HIV-negative cryptococcal meningitis had seizures, including 13 with early seizures and 15 with late seizures. The mean time interval from HIV-negative cryptococcal meningitis to first seizure in the early and late seizure groups were 1.5 and 51.4 days, respectively. Nine out of the 28 cases (32%) occurred within 24 hours of presentation. The overall mortality rate was 54% (15/28) and two patients progressed to epilepsy.

Conclusions: Patients with seizure have worse outcomes and longer hospitalization. Most first seizures occur within one year after the diagnosis of HIV-negative cryptococcal meningitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacology
  • Disease Progression*
  • Female
  • Humans
  • Male
  • Meningitis, Cryptococcal / complications
  • Meningitis, Cryptococcal / drug therapy
  • Meningitis, Cryptococcal / mortality*
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Seizures / etiology
  • Seizures / mortality*
  • Treatment Outcome
  • Young Adult

Substances

  • Antifungal Agents